Ringera-atsetat

General characteristics. Structure:

Active ingredients: 5,91 g of sodium of chloride, 2,82 g of sodium of acetate (in terms of anhydrous), 0,3 g of potassium of chloride, 0,22 g of Calcii chloridum (in terms of anhydrous), 0,095 g of magnesium of chloride (in terms of anhydrous).

Excipients: water for injections.

Pharmacological properties:

Pharmacodynamics. The combined drug, eliminates a metabolic acidosis, normalizes an acid-base condition and water and electrolytic composition of blood. The medical effect of drug is caused by temporary increase in volume of the blood circulating in vessels, completion of deficit of ions of sodium, potassium and calcium, and also transformation of an ion of acetate into bicarbonate.

Indications to use:

Shock, thermal injury, acute blood loss; hydropenia (isotonic and hypotonic forms); metabolic acidosis; acute diffuse peritonitis, intestinal impassability (for correction of water and salt balance); a decompensation of electrolytic disturbances at patients with intestinal fistulas; a medical plasma exchange (dialysis - a filtrational method).

Route of administration and doses:

Intravenously kapelno. The adult — with a speed of 60-80 of caps/mines or struyno, a daily dose 5-20¼½/kg, if necessary — 30-40 ml/kg.

Daily dose for children — 5-10 ml/kg, rate of administering — 30-60 caps/min. A course of treatment — 3-5 days.

At a medical plasma exchange enter in twofold volume in comparison with remote plasma (1,2-2,4 l), in combination with colloidal solutions (in case of the expressed hypovolemia).

Features of use:

At treatment of the expressed hypovolemia simultaneous therapy with colloidal solutions, blood and its components is recommended (owing to short effect of drug). At long introduction of high doses of solution it is desirable to carry out control of electrolytes in plasma and urine.

Side effects:

Allergic reactions. Introduction of large volumes of solution can lead to an overhydratation, chloride acidosis, a hypernatremia.

Contraindications:

Hypersensitivity, alkalosis, extracellular overhydratation, heavy chronic heart failure, wet brain, anury.

With care: heart failure, arterial hypertension, renal and/or hepatic insufficiency, oliguria.

Storage conditions:

Period of validity - 3 years. Not to use after the period of validity specified on packaging. To store in the place, dry, unavailable to children, at a temperature not above 25 °C. Freezing at transportation is allowed.

Issue conditions:

According to the recipe

Packaging:

Solution for infusions on 100, 250, 500 and 1000 ml in polymeric containers. Each container is packed into a polymeric package. Containers in packages stack in boxes from corrugated fibreboard.